Barchart on MSN
What to expect from Revvity’s Q4 2025 earnings report
Revvity, Inc. (RVTY) is a Massachusetts-based life sciences and diagnostics company formed in 2023. It provides instruments, ...
Revvity, Inc. (NYSE:RVTY) is one of the stocks Jim Cramer recently discussed. Cramer highlighted the company’s cheap valuation compared to its group, as he said: “Now, I’ve got two more smaller life ...
Investors were disappointed with the weak earnings posted by Revvity, Inc. (NYSE:RVTY). Despite the soft profit numbers, our analysis has optimistic about the overall quality of the income statement.
Revvity (RVTY) shares have drawn investor attention after the company released its latest financial results, which highlight annual growth in both revenue and net income. The market is reacting to ...
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced the launch of Revvity Transcribe AI, an innovative optical character recognition (OCR) service designed to convert ...
Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop
Revvity Inc. (NYSE:RVTY) stock is trading higher on Monday after the company reported better-than-expected first-quarter 2025 earnings. The Waltham, Massachusetts-based company reported first-quarter ...
Waltham-based biomanufacturing company Revvity is closing its Boston facility and laying off dozens of employees as a result. Revvity filed a public Worker Adjustment and Retraining Act Notification ...
With the sell-off of its applied science, food and enterprise services businesses now complete, PerkinElmer is charting a new path with its remaining diagnostics and life sciences divisions. The first ...
WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. (NYSE: RVTY) announced that it has filed a complaint against Cloud Software Group (CSG) in Massachusetts Superior Court and requested injunctive ...
Revvity announced weaker-than-expected third-quarter results and lowered its full-year outlook. CEO Prahlad Singh blamed today's "increasingly challenging end market environment," but insists the ...
When PerkinElmer’s diagnostics and life sciences businesses separated from its food safety, environmental testing and industrial quality assurance segments and rebranded as Revvity earlier this year, ...
New software further strengthens Revvity’s market-leading position in in vivo imaging while empowering scientists with faster, more reproducible insights Today Revvity, Inc. (NYSE: RVTY), announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results